Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03889197 · ClinicalTrials.gov registry record · Phase 4
Physiologic Approach to Sodium Supplementation in Premature Infants
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT03889197 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 90 participants.
The verdict
NCT03889197, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
Postnatal growth failure occurs in up to 50% of very low birth weight (VLBW, \<1500 grams at birth) infants as assessed by discharge weight. This study will evaluate if a sodium supplementation algorithm guided by spot urine sodium measurements can improve postnatal growth.
Interventions
- DRUG Sodium supplementation guided by urine sodium concentration algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2023-08-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03889197
The ClinicalTrials.gov registry entry for NCT03889197 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sodium supplementation guided by urine sodium concentration algorithm is the first listed.
NCT03889197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03889197 about?
NCT03889197 is a clinical study titled "Physiologic Approach to Sodium Supplementation in Premature Infants". Postnatal growth failure occurs in up to 50% of very low birth weight (VLBW, \<1500 grams at birth) infants as assessed by discharge weight. This study will evaluate if a sodium supplementation algorithm guided by spot urine sodium measurements can improve postnatal growth.
What is the current status of trial NCT03889197?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2019-07-01. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT03889197?
The interventions under investigation include: Sodium supplementation guided by urine sodium concentration algorithm (DRUG).
Who is sponsoring clinical trial NCT03889197?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.